author-photo

Joshua T. Kantrowitz

Columbia University
Nathan Kline Institute for Psychiatric Research

79

Papers

2485

Citations

Citation Trend

Filter By

Papers (58) Sort By

Journal Conference Others

D-Serine: A Cross Species Review of Safety.

2021 Frontiers in Psychiatry
Show All
- Source
- Cite
- Save
Citations (1)
Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions.

2021 CNS Drugs
- Joshua T. Kantrowitz
Show All
- Source
- Cite
- Save
Citations (0)
Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study.

2021 Frontiers in Psychiatry
Show All
- Source
- Cite
- Save
Citations (4)
D-Serine Safety: A Cross Species Review

2021 Biological Psychiatry
- Amir M Meftah
- Joshua T. Kantrowitz
Show All
- Source
- Cite
- Save
Citations (0)
CVN058, a 5-HT3 Receptor Antagonist, Shows Acute, Dose Dependent Improvement of Mismatch Negativity in a Double-Blind, Placebo-Controlled, Single Dose Cross-Over Study in Schizophrenia and Schizoaffective Disorder

2021 Biological Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia.

2021 Frontiers in Psychiatry
Show All
- Source
- Cite
- Save
Citations (3)
Improving reproducibility of proton MRST by optimally averaging temperatures measured from multiple references: theoretical and empirical approaches

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.

2021 Schizophrenia Bulletin
Show All
- Source
- Cite
- Save
Citations (0)
Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder

2021 Translational Psychiatry
Show All
- Source
- Cite
- Save
Citations (1)
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers.

2020 Neuropsychopharmacology
Show All
- Source
- Cite
- Save
Citations (14)